Cloxacillin induced agranulocytosis: A rare adverse event of a commonly used antibiotic

Cloxacillin induced agranulocytosis: A rare adverse event of a commonly used antibiotic

Cloxacillin, a semisynthetic penicillin is a potent inhibitor of most penicillinase-producing Staphylococci. Use of high doses of Cloxacillin for 6 weeks is recommended for the treatment of infective endocarditis caused by methicillin-susceptible Staphylococcus aureus (MSSA). Here, we report a case of Cloxacillin-induced agranulocytosis in a patient treated for MSSA native tricuspid valve endoc...

Choreoathetosis Is a Possible Adverse Event of a Commonly Used Antibiotic

BACKGROUND Choreoathetosis (CAS) is attributed to a few neuropsychiatric drugs; however, it is scarcely reported with commonly used antibiotics. AIMS To present a case of ceftriaxone (CTX)-induced CAS and to perform a literature review. SETTING A medical teaching hospital. CASE HISTORY An 83-year-old female with end stage renal disease was prescribed CTX 2 g/day intravenously and doxycycl...

Propylthiouracil Induced Vasculitis: A Rare Adverse Event

Minocycline-Associated Pancreatitis: A Rare Adverse Effect of a Commonly used Drug

Minocycline is an antibiotic used increasingly in a variety of situations including MRSA infections and also known for its anti-inflammatory properties. Its side effects are usually benign and well known. We report a first of its kind case of minocycline-associated acute pancreatitis in a patient in whom all other common causes of pancreatitis were ruled out. The aim is to raise awareness about...

Doxycycline-Induced Acute Pancreatitis: A Rare Adverse Event

Doxycycline is a broad-spectrum antibiotic belonging to the tetracycline group which acts by inhibiting bacterial protein synthesis. It is considered to be a relatively safe drug. We report a case of doxycycline-induced acute pancreatitis (DIAP) in an adult female patient who was started on the usual therapeutic dose 1 week before for acne vulgaris. The WHO causality assessment was possible, an...